Fridays vs Hers
Hers costs $50 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Fridays
Best for: coaching bundled into the price rather than sold separately
Visit Fridays →
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →If you are choosing between Fridays and Hers, the first difference is cost: Hers is $50 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hers leads our six-part score, 7.0 to 5.5.
Fridays vs Hers price
Hers is the cheaper way in: $199 a month against $249 a month at Fridays. That is $50 less each month (20% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Hers ($199 a month vs $249 a month); tirzepatide is cheaper at Hers ($299 a month vs $359 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections and brand-name pens.
Where each one treats patients
Fridays does not publish where it ships, and Hers lists 50 states.
Pricing
Fridays
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
What each price covers
Both prices cover the medication itself.
Fridays' price also covers the clinician visit and coaching, which Hers does not claim.
Fridays is silent on shipping and lab work.
Hers is silent on shipping and lab work.
Fridays
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, Hers scores 7.0 and Fridays 5.5 out of 10.
Fridays is stronger on support (7.0 vs 3.0).
Hers is stronger on user experience (8.0 vs 3.0), trust & safety (8.5 vs 4.0) and accessibility (10.0 vs 5.0).
Value and effectiveness are within half a point.
Fridays
5.5/10
Hers
7.0/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Fridays nor Hers has an FDA warning letter on record with us.
Features & Coverage
| Feature | Fridays | Hers |
|---|---|---|
| Starting Price | $249/mo | ✓$199/mo |
| Features | 2 features | 2 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Fridays
Fridays is a telehealth weight loss seller running compounded GLP-1 programs.
Read our full Fridays review →About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →Pros & Cons
Fridays
What we like
- The monthly price includes the medication, clinician visits and coaching
- We found no FDA warning letters issued to Fridays
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- We found no FDA warning letters issued to Hers
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hers wins this one, 7.0 to 5.5, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $50 less each month than Fridays. Fridays fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Fridays if…
You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Fridays vs Hers: FAQ
Close alternatives to Fridays and Hers
- Fridays vs Luvo Health
- Fridays vs RxSpan MD
- Fridays vs Elevated Health
- Fridays vs Better U Care
- Hers vs Hims
- Hers vs Noom
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.